EP12.13: Instigating multi‐professional management of pregnant women with cardiac disease

R. Parasuraman,L. Stocker,L. Relton,P. Mackie,E. Jolly,S. Fitzsimmons,A. Carroll

DOI: https://doi.org/10.1002/uog.28565

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 240-240, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics

What problem does this paper attempt to address?

EP12.10: Cardiac disease in pregnancy and perinatal outcomes

R.A. Al Thobaiti,I. Babic

DOI: https://doi.org/10.1002/uog.28562

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 239-239, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Ischemic heart disease in pregnancy: a practical approach to management

Andrew H Nguyen,Ellen Murrin,Axucillia Moyo,Garima Sharma,Scott A Sullivan,George L Maxwell,Jamie L W Kennedy,Antonio F Saad

DOI: https://doi.org/10.1016/j.ajogmf.2024.101295

Abstract:Ischemic heart disease is a crucial issue during pregnancy. The term is composed of both preexisting conditions and acute coronary syndrome in pregnancy, including pregnancy-associated myocardial infarction, which can have a significant effect on maternal and fetal outcomes. This review provides a complete guide to managing ischemic heart disease in pregnant women, emphasizing the importance of multidisciplinary care and individualized treatment strategies. Cardiovascular disease, particularly ischemic heart disease, is now the leading cause of maternal mortality worldwide. Pregnancy introduces unique physiological changes that increase the risk of acute myocardial infarction, with pregnancy-associated myocardial infarction cases often associated with factors, such as advanced maternal age, chronic hypertension, and preexisting cardiovascular conditions. This review distinguishes between preexisting ischemic heart disease and pregnancy-associated myocardial infarction. It will emphasize the various etiologies of pregnancy-associated myocardial infarction, including coronary atherosclerosis and plaque rupture presenting as ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and other nonatherosclerotic causes, including spontaneous coronary artery dissection, vasospasm, and embolism. Our study discusses the practical management of ischemic heart disease in pregnancy, with a focus on preconception counseling, risk assessment, and tailored antenatal planning for women with preexisting ischemic heart disease. Moreover, this document focuses on the challenges of diagnosing cardiovascular disease, especially when presented with nonclassical risk factors and presentation. It provides insight into the appropriate diagnostic testing methods, such as electrocardiogram, cardiac biomarkers, and echocardiography. In addition, the review covers various treatment strategies, from medical management to more invasive procedures, including coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft. Special attention is given to medication safety during pregnancy, including anticoagulation, beta-blockers, and antiplatelet agents. The complexities of delivery planning in women with ischemic heart disease are discussed, advocating for a multidisciplinary team-based approach and careful consideration of the timing and mode of delivery. Furthermore, the roles of breastfeeding and postpartum care are explored, emphasizing the long-term benefits and the suitability of various medications during lactation. Lastly, this review provides crucial insights into the management of ischemic heart disease in pregnancy, stressing the need for heightened awareness, prompt diagnosis, and tailored management to optimize maternal and fetal health outcomes.
EP11.24: Management of a high‐risk pregnancy associating autoimmune diseases, chronic hypertension, prediabetes and inherited thrombophilia

M. Neagu,N. Patrascu,I. Rosca

DOI: https://doi.org/10.1002/uog.28547

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 236-236, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Management and outcomes of pregnant women with cardiovascular diseases in a cardio-obstetric team

Marjorie Richardson,Jean Philippe Bonnet,Capucine Coulon,Olivia Domanski,Benjamin Constans,Max Gonzalez Estevez,Sophie Gautier,Luisa Marsili,Yasmine Ould Hamoud,Augustin Coisne,Hélène Ridon,Anne-Sophie Polge,Stéphanie Mouton,Yasmine Haddad,Francis Juthier,Mouhamed Moussa,Claire Mounier Vehier,Gilles Lemesle,Guillaume Schurtz,Charles Garabedian,Mercedes Jourdain,Sandro Ninni,François Brigadeau,David Montaigne,Nicolas Lamblin,Louise Ghesquiere

DOI: https://doi.org/10.1016/j.acvd.2024.02.009

Abstract:Background: Cardiovascular diseases (CVDs) are currently the leading cause of maternal death in Western countries. Although multidisciplinary cardio-obstetric teams are recommended to improve the management of pregnant women with CVD, data supporting this approach are scarce. Aims: To describe the characteristics and outcomes of pregnant patients with CVD managed within the cardio-obstetric programme of a tertiary centre. Methods: We included every pregnant patient with history of CVD managed by our cardio-obstetric team between June 2017 and December 2019, and collected all major cardiovascular events (death, heart failure, acute coronary syndromes, stroke, endocarditis and aortic dissection) that occurred during pregnancy, peripartum and the following year. Results: We included 209 consecutive pregnancies in 202 patients. CVDs were predominantly valvular heart diseases (37.8%), rhythm disorders (26.8%), and adult congenital heart diseases (22.5%). Altogether, 47.4% were classified modified World Health Organization (mWHO)>II, 66.5% had CARdiac disease in PREGnancy score (CARPREG II)≥2 and 80 pregnancies (38.3%) were delivered by caesarean section. Major cardiovascular events occurred in 16 pregnancies (7.7%, 95% confidence interval [CI] 4.5-12.2) during pregnancy and in three others (1.5%, 95% CI 0.3-4.1) during 1-year follow-up. Most events (63.1%) occurred in the 16.3% of patients with unknown CVD before pregnancy. Conclusions: The management of pregnant patients with CVD within a cardio-obstetric team seems encouraging as we found a relatively low rate of cardiovascular events compared to the high-risk profile of our population. However, most of the remaining events occurred in patients without cardiac monitoring before pregnancy.
Creating a Multidisciplinary Pregnancy Heart Team

Sarah Rae Easter,Anne Marie Valente,Katherine E Economy

DOI: https://doi.org/10.1007/s11936-020-0800-x

2020-01-27

Abstract:Purpose of review: Cardiovascular disease (CVD) is the leading cause of maternal death and cases of cardiovascular death are often associated with failure to provide timely risk-appropriate care. This review outlines considerations for creation of a team focused on the care of women with CVD during pregnancy and beyond. Recent findings: Improved outcomes for women with complex medical or obstetric conditions managed by a multidisciplinary care team inspired national guidelines advising the creation of a Pregnancy Heart Team for women with CVD in pregnancy. The recommendations from the European Society of Cardiology provide general guidance for risk-appropriate care without elaborating on the details of these specialized care teams. A Pregnancy Heart Team led by providers from cardiology, maternal-fetal medicine, obstetrics, obstetric anesthesia, pharmacy, and nursing support a holistic approach to patient care while facilitating opportunities for cross-disciplinary education. This team should focus on frequent antepartum risk stratification, multidisciplinary delivery planning, and comprehensive preconception and postpartum care. Available evidence suggests that a consistent and integrated approach to care for women with CVD in pregnancy has the potential to decrease severe maternal morbidity and mortality. The cost-effectiveness of this approach and the impact of this comprehensive care model on a woman's long-term cardiovascular health warrant future study.
Obstetric echodynamics: Approaching a new field of multidisciplinary action

Gianluca Bertschy,Mario Iannaccone,Walter Grosso Marra,Fabrizio Bogliatto

DOI: https://doi.org/10.1016/j.ijcard.2024.131850

IF: 4.039

2024-02-13

International Journal of Cardiology

Abstract:Maternal cardiovascular adaptation during pregnancy is essential for fetal development. Structural and functional changes, including increased blood volume, heart rate, and myocardial hypertrophy, are crucial for optimal tissue perfusion. Recent evidence supports viewing maternal and fetal cardiovascular systems as a unified functional unit, emphasizing the significance of hemodynamic evaluation in pregnancy. Some obstetrical syndromes result from maladaptive maternal cardiovascular responses. Non-invasive hemodynamic tests, like transthoracic echocardiography, aid in distinguishing phenotypes, guiding tailored management strategies for hypertensive disorders. Establishing obstetric hemodynamics as a multidisciplinary field, termed "Obstetric Echodynamics," promises improved clinical care through standardized practices, interdisciplinary cooperation, and enhanced education.

cardiac & cardiovascular systems
Caring for two in the ICU: Pharmacologic management of pregnancy-related complications

Mojdeh S Heavner,Michaelia D Cucci,Brooke Barlow,Carolyn Magee Bell,Claire C Eng,Grace Erdman,Matthew Li,Susan E Smith,Mohammed Aldhaeefi,Melissa L Thompson Bastin,W Anthony Hawkins,Christina Rose,Allison Lankford

DOI: https://doi.org/10.1002/phar.2837

Pharmacotherapy

Abstract:Maternal mortality continues to be an issue globally despite advances in technology and pharmacotherapy. Pregnancy can lead to complications that necessitate immediate action to prevent severe morbidity and mortality. Patients may need escalation to the ICU setting for close monitoring and administration of advanced therapies not available elsewhere. Obstetric emergencies are rare but high-stakes events that require clinicians to have prompt identification and management. The purpose of this review is to describe complications of pregnancy and provide a focused resource of pharmacotherapy considerations that clinicians may encounter. For each disease state, the epidemiology, pathophysiology, and management are summarized. Brief descriptions of non-pharmacological (e.g., cesarean or vaginal delivery of the baby) interventions are provided. Mainstays of pharmacotherapy highlighted include oxytocin for obstetric hemorrhage, methotrexate for ectopic pregnancy, magnesium and antihypertensive agents for preeclampsia and eclampsia, eculizumab for atypical hemolytic uremic syndrome, corticosteroids, and immunosuppressive agents for thrombotic thrombocytopenic purpura, diuretics, metoprolol, and anticoagulation for peripartum cardiomyopathy, and pulmonary vasodilators for amniotic fluid embolism.
Cardiovascular complications during pregnancy: Advancing cardio-obstetrics

Sneha Annie Sebastian,Yashendra Sethi,Arpita Mariam Mathews,Tony Santhosh,Edzel Lorraine Co,Inderbir Padda,Gurpreet Johal

DOI: https://doi.org/10.1016/j.disamonth.2024.101780

IF: 4.477

2024-06-25

Disease-a-Month

Abstract:As the incidence of cardiovascular diseases (CVDs) continues to rise among women of childbearing age, the pregnant population with pre-existing heart conditions presents a complex and heterogeneous profile. These women face varying degrees of risk concerning maternal cardiovascular, obstetric, and fetal complications. Effectively managing adverse cardiovascular events during pregnancy presents substantial clinical challenges. The uncertainties surrounding diagnostic and therapeutic approaches create a dynamic landscape with potential implications for maternal and fetal health. Cardio-obstetrics has become increasingly recognized as a vital multidisciplinary field necessitating a collaborative approach to managing cardiovascular conditions during pregnancy. In this review, we aim to provide a thorough and up-to-date examination of the existing evidence, offering a comprehensive overview of strategies and considerations in the management of cardiovascular complications during pregnancy. Special emphasis is placed on the safety assessment of diagnostic procedures and the exploration of treatment options designed to prioritize the well-being of the mother and fetus. We also explore the significance of a multidisciplinary cardio-obstetrics team in providing comprehensive care for women of childbearing age with or at risk for CVD.

medicine, general & internal
Preliminary data on short-term outcomes within the cardio-obstetrics registry

D S Siry,I H Hoerbrand,A C H Haney,N F Frey,P E Ehlermann,J B Beckendorf

DOI: https://doi.org/10.1093/eurheartj/ehae666.3099

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Pregnancy leads to physiological changes within the cardiovascular system such as increased plasma volume and cardiac output or hypercoagulability. These changes can be challenging for women with pre-existing cardiovascular disease with higher risks of complications. The guidelines of the European Society of Cardiology recommend treating high-risk patients in specialized centres by an interdisciplinary pregnancy heart team. In a team-based approach, the Pregnancy Heart Team was founded at our university hospital, in order to establish specific structures of communication and responsibility. Methods A prospective registry of all patients treated by the Pregnancy Heart Team between November 2022 and March 2024 was established. Patients consisted of women with pre-existing cardiovascular disease undergoing pregnancy as well as women who developed pregnancy-associated cardiovascular disease. Patients were evaluated throughout pregnancy by lab work and echocardiography during each trimester as well as in the postpartum period. Results In total 39 women (mean age 34±5 years) were prospectively included in the registry. 17 patients (43.5%) were classified as mWHO ≥ III. 17 patients (43.5 %) with pre-existing (pregnancy-associated) cardiovascular disease were managed throughout pregnancy and delivery. 9 patients (18.4 %) developed pregnancy-associated cardiovascular diseases such as peripartum cardiomyopathy or spontaneous coronary artery dissection. Preliminary data shows that mean left-ventricular ejection fraction remained stable during pregnancy with a non-significant trend towards lower values postpartum. Cardiac biomarkers such as high-sensitivity troponin T and NT-pro-BNP showed a non-significant trend towards increased values in the third trimester and postpartum. Adverse maternal outcomes occurred in 14 patients (35.9 %), including preterm premature rupture of membranes (12.2%), gestational hypertension (7.6%), gestational diabetes (5.1%), preeclampsia/eclampsia (7.6%) and delivery-associated complications (10.2%). Fetal complications included macrosomia (10.2%) or intrauterine growth retardation (5.1%). Discussion These preliminary data of a real-world patient collectivedemonstrate that a significant number of patients experienced adverse pregnancy outcomes which was associated with a trend towards increased cardiac biomarkers throughout pregnancy and postpartum. As recent studies have shown, interpretation of standard parameters such as cardiac biomarkers is not fully understood during pregnancy, especially in women with pre-existing cardiovascular disease. Our data may aid to understand prognostic implications of cardiac biomarkers during pregnancy.

cardiac & cardiovascular systems
Pregnancy and pulmonary hypertension: a practical approach to management

David G Kiely,Robin Condliffe,Vicki J Wilson,Suarabh V Gandhi,Charlie A Elliot

DOI: https://doi.org/10.1177/1753495x13495193

2013-08-08

Obstetric Medicine

Abstract:Pulmonary hypertension remains a major cause of cardiac maternal death in the developed world. Over the last two decades, effective therapies for pulmonary hypertension have been developed, improving symptoms and survival. Consequently, increasing numbers of women with pulmonary hypertension and childbearing potential exist, with a number considering pregnancy. Patients with pulmonary hypertension may also present for the first time during pregnancy or shortly following delivery. The last decade has seen increasing reports of women with pulmonary hypertension surviving pregnancy using a variety of approaches but there is still a significant maternal mortality at between 12% and 33%. Current recommendations counsel that patients with known pulmonary hypertension should be strongly advised to avoid pregnancy with the provision of clear contraceptive advice and termination of pregnancy should be considered in its eventuality. In patients who are fully informed and who have been counselled regarding the risks of continuing with pregnancy, there is growing evidence that a multi-professional approach with expert care in pulmonary hypertension centres may improve outlook, although the mortality remains high.

English Else
OP13.03: "Inverting the pyramid" of specialist antenatal care in Australia: the Initial Maternity Assessment and Planning Service

A. Borbolla Foster,J. Hyett,F. Park

DOI: https://doi.org/10.1002/uog.27977

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 93-93, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel

Emily S Lau,Niti R Aggarwal,Joan E Briller,Daniela R Crousillat,Katherine E Economy,Colleen M Harrington,Kathryn J Lindley,Isabelle Malhamé,Deirdre J Mattina,Marie-Louise Meng,Selma F Mohammed,Odayme Quesada,Nandita S Scott,ACC Cardiovascular Disease in Women Committee

DOI: https://doi.org/10.1016/j.jacadv.2024.100901

2024-03-18

Abstract:Maternal mortality is a major public health crisis in the United States. Cardiovascular disease (CVD) is a leading cause of maternal mortality and morbidity. Labor and delivery is a vulnerable time for pregnant individuals with CVD but there is significant heterogeneity in the management of labor and delivery in high-risk patients due in part to paucity of high-quality randomized data. The authors have convened a multidisciplinary panel of cardio-obstetrics experts including cardiologists, obstetricians and maternal fetal medicine physicians, critical care physicians, and anesthesiologists to provide a practical approach to the management of labor and delivery in high-risk individuals with CVD. This expert panel will review key elements of management from mode, timing, and location of delivery to use of invasive monitoring, cardiac devices, and mechanical circulatory support.
Acute Management of Cardiac Complications in Pregnancy

Siamak Moayedi

DOI: https://doi.org/10.4172/2161-0932.1000245

2014-01-01

Abstract:Acute Management of Cardiac Complications in Pregnancy,<p>Siamak Moayedi</p>
EP11.21: Management of ovarian masses in pregnancy

S. Kostic,M. Petronijevic,S. Vrzic Petronijevic,K. Ivanovic,I. Jovanovic,M. Petronijevic,D. Bratic,S. Kadija,S. Dugalic,T. Igic

DOI: https://doi.org/10.1002/uog.28544

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 235-236, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
[Internal medical emergencies in the pregnant patient : Peripartum sepsis, metabolic derailment, endocrinological emergencies and pulmonary edema]

J Fischer,G Gerresheim,U Schwemmer

DOI: https://doi.org/10.1007/s00063-022-00910-y

Abstract:Peripartum emergencies that require intensive medical care represent a major challenge for the interdisciplinary treatment team. Due to physiological changes in pregnant women symptoms can be masked and the initiation of treatment is delayed. Peripartum sepsis has a relatively high incidence. The anti-infective treatment depends on the spectrum of pathogens to be expected. Endocrinological emergencies are rare but can be fulminant and fatal. The development of ketoacidosis is favored by decreased bicarbonate buffer and placental hormones. In the case of thyrotoxicosis, propylthiouracil and thiamazole are available for treatment depending on the stage of gestation. Sheehan's syndrome is an infarction of the anterior lobe of the pituitary gland during a hemorrhage. Due to the loss of production of vital hormones, this can be fatal. The development of pulmonary edema is just as acute. This is favored by physiological changes during pregnancy. The differentiation between hypertensive and hypotensive pulmonary edema is important for the causal treatment.
Echocardiography for Management of Cardiovascular Disease in Pregnancy

Mary Rodriguez Ziccardi,Joan E Briller

DOI: https://doi.org/10.1007/s11886-024-02126-2

Abstract:Purpose of review: Cardiovascular disease (CVD) continues to be a leading contributor to maternal mortality and morbidity. Echocardiography is an essential tool for patients with suspected and known CVD to establish symptom etiology, treatment strategy, and prognosis. We summarize the current status of conventional and novel techniques for assessment of CVD during pregnancy. Recent findings: Conventional techniques are still useful for evaluation of known or suspected CVD. Advanced technology using speckle tracking continues to evolve and is increasingly applied for diagnosis of subclinical disease including hypertensive disorders of pregnancy and left ventricular (LV) dysfunction. Precise recommendations on how frequently echocardiography should be performed and for whom remain in flux. However, a recently published consensus statement and new screening tool for pregnancy assessment of patients with valvular heart disease provide additional advice on using this modality. Echocardiography remains the diagnostic modality of choice for evaluation and risk stratification in pregnancy.
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC

Amina Rakisheva,Karen Sliwa,Johann Bauersachs,Sophie Van Linthout,Vijay K. Chopra,Antoni Bayes‐Genis,Franca Fruzzetti,Antonio Cannatà,Benjamin Deniau,Alexandre Mebazaa,Gianluigi Savarese,Robin Ray,Cristiana Vitale,Marco Metra,Giuseppe M.C. Rosano

DOI: https://doi.org/10.1002/ejhf.3246

2024-04-30

European Journal of Heart Failure

Abstract:Heart failure is the most common cardiovascular complication during pregnancy and the postpartum period. It is associated with increased risk of maternal morbidity and mortality as well as potentially life‐threatening foetal pathology. Management of heart failure in pregnancy requires expert knowledge of cardiovascular disease as well as obstetrics which underscores the importance of multidisciplinary cardio‐obstetrics teams in order to optimize diagnosis, treatment and outcome. This includes counselling of women at risk before and during the course of pregnancy in order to strengthen the relationship between medical specialists and patients, as well as to allow patient‐centred delivery of care and improve quality of life.

cardiac & cardiovascular systems
EP12.12: Agreement between two different devices for maternal hemodynamic evaluation

G. Zamagni,T. Stampalija,L. Monasta,R. Erra,L. Jones,B. Mylrea‐Foley,J. Goodier,C. Lees

DOI: https://doi.org/10.1002/uog.28564

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 239-240, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics
Perioperative Management of an Obstetric Patient with Eisenmenger Syndrome and Pre-Eclampsia Using Milrinone

C D Deepak Chakravarthy,Chitra Rajeswari Thangaswamy,Hemavathi Balachander

DOI: https://doi.org/10.4103/aca.aca_191_23

2024-07-01

Abstract:Pregnancy in a patient with pulmonary hypertension carries a high risk of mortality. It poses multiple problems in the management of pregnancy, labor, and postpartum, thereby emphasizing the need for a multidisciplinary team for a successful outcome. We describe the successful management of a case of Eisenmenger syndrome who developed pre-eclampsia during her 28 weeks of pregnancy. As far as our knowledge, this is the first case report that describes the use of milrinone in a parturient for a successful outcome.
EP19.13: "Opt‐out" use of intrapartum sonographic assessment at prolonged second stage of labour: a single‐centre experience

Y. Chan,W. Chan,H. Chan,W. Lau

DOI: https://doi.org/10.1002/uog.28796

2024-09-11

Ultrasound in Obstetrics and Gynecology

Abstract:Ultrasound in Obstetrics &Gynecology, Volume 64, Issue S1, Page 298-299, September 2024.

radiology, nuclear medicine & medical imaging,obstetrics & gynecology,acoustics

EP12.13: Instigating multi‐professional management of pregnant women with cardiac disease

EP12.10: Cardiac disease in pregnancy and perinatal outcomes

Ischemic heart disease in pregnancy: a practical approach to management

EP11.24: Management of a high‐risk pregnancy associating autoimmune diseases, chronic hypertension, prediabetes and inherited thrombophilia

Management and outcomes of pregnant women with cardiovascular diseases in a cardio-obstetric team

Creating a Multidisciplinary Pregnancy Heart Team

Obstetric echodynamics: Approaching a new field of multidisciplinary action

Caring for two in the ICU: Pharmacologic management of pregnancy-related complications

Cardiovascular complications during pregnancy: Advancing cardio-obstetrics

Preliminary data on short-term outcomes within the cardio-obstetrics registry

Pregnancy and pulmonary hypertension: a practical approach to management

OP13.03: "Inverting the pyramid" of specialist antenatal care in Australia: the Initial Maternity Assessment and Planning Service

Recommendations for the Management of High-Risk Cardiac Delivery: ACC Cardiovascular Disease in Women Committee Panel

Acute Management of Cardiac Complications in Pregnancy

EP11.21: Management of ovarian masses in pregnancy

[Internal medical emergencies in the pregnant patient : Peripartum sepsis, metabolic derailment, endocrinological emergencies and pulmonary edema]

Echocardiography for Management of Cardiovascular Disease in Pregnancy

Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC

EP12.12: Agreement between two different devices for maternal hemodynamic evaluation

Perioperative Management of an Obstetric Patient with Eisenmenger Syndrome and Pre-Eclampsia Using Milrinone

EP19.13: "Opt‐out" use of intrapartum sonographic assessment at prolonged second stage of labour: a single‐centre experience